Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination

Background: Relevant serum tumor markers have been indicated to be associated with peritoneal dissemination (PD) of gastric cancer (GC). Fibrinogen has been shown to play an important role in the systemic inflammatory response (SIR) and in tumor progression. However, the clinical significance of the...

Full description

Bibliographic Details
Main Authors: Chao Huang, Zitao Liu, Li Xiao, Yongqiang Xia, Jun Huang, Hongliang Luo, Zhen Zong, Zhengming Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01159/full
_version_ 1811197295132147712
author Chao Huang
Zitao Liu
Li Xiao
Yongqiang Xia
Jun Huang
Hongliang Luo
Zhen Zong
Zhengming Zhu
author_facet Chao Huang
Zitao Liu
Li Xiao
Yongqiang Xia
Jun Huang
Hongliang Luo
Zhen Zong
Zhengming Zhu
author_sort Chao Huang
collection DOAJ
description Background: Relevant serum tumor markers have been indicated to be associated with peritoneal dissemination (PD) of gastric cancer (GC). Fibrinogen has been shown to play an important role in the systemic inflammatory response (SIR) and in tumor progression. However, the clinical significance of the fibrinogen-to-lymphocyte ratio (FLR) in GC with PD has not been studied.Methods: The clinical data of 391 patients with GC were collected, including 86 cases of PD. Then, 1:3 matching was performed by propensity score matching (PSM), and the clinical data of the matched 344 patients were analyzed by univariate and multivariate conditional logistic regression. Classification tree analysis was used to obtain the decision rules and a random forest algorithm to extract the important risk factors of PD in GC. A nomogram model for risk assessment of PD in GC was established by using the rms package of R software.Results: Univariate analysis showed that the factors related to PD in GC were: carbohydrate antigen (CA) 125 (P < 0.0001), CA19-9 (P < 0.0001), CA72-4 (P < 0.0001), FLR (P < 0.0001), neutrophil-to-lymphocyte ratio (NLR) (P < 0.0001), albumin-to- lymphocyte ratio (ALR) (P < 0.0001), platelet-to-lymphocyte ratio (PLR) (P = 0.013), and carcinoembryonic antigen (CEA) (P = 0.031). Conditional logistic regression found that CA125 (OR: 1.046; P < 0.0001), CA19-9 (OR: 1.002; P < 0.0001), and FLR (OR: 1.266; P = 0.024) were independent risk factors for GC with PD. The accuracy, sensitivity, specificity, positive predictive value and negative predictive value of the decision rules for detecting PD of GC were 89.5, 77.4, 94.0, 82.8, and 91.8%, respectively. According to the important variables identified by the classification tree and random forest algorithm, the risk assessment model of PD in GC was established. The accuracy, sensitivity, and specificity of the model were 91, 89.5, and 79.5%, respectively.Conclusion: CA125 > 17.3 U/ml, CA19-9 > 27.315 U/ml, and FLR > 2.555 were the risk factors for GC with PD. The decision rules and nomogram model constructed by CA125, CA19-9, CA72-4, and FLR can correctly predict the risk of PD in GC.
first_indexed 2024-04-12T01:11:41Z
format Article
id doaj.art-f84ca1aaa67b43cdbe1844c10828910c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T01:11:41Z
publishDate 2019-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f84ca1aaa67b43cdbe1844c10828910c2022-12-22T03:54:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-11-01910.3389/fonc.2019.01159490735Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal DisseminationChao HuangZitao LiuLi XiaoYongqiang XiaJun HuangHongliang LuoZhen ZongZhengming ZhuBackground: Relevant serum tumor markers have been indicated to be associated with peritoneal dissemination (PD) of gastric cancer (GC). Fibrinogen has been shown to play an important role in the systemic inflammatory response (SIR) and in tumor progression. However, the clinical significance of the fibrinogen-to-lymphocyte ratio (FLR) in GC with PD has not been studied.Methods: The clinical data of 391 patients with GC were collected, including 86 cases of PD. Then, 1:3 matching was performed by propensity score matching (PSM), and the clinical data of the matched 344 patients were analyzed by univariate and multivariate conditional logistic regression. Classification tree analysis was used to obtain the decision rules and a random forest algorithm to extract the important risk factors of PD in GC. A nomogram model for risk assessment of PD in GC was established by using the rms package of R software.Results: Univariate analysis showed that the factors related to PD in GC were: carbohydrate antigen (CA) 125 (P < 0.0001), CA19-9 (P < 0.0001), CA72-4 (P < 0.0001), FLR (P < 0.0001), neutrophil-to-lymphocyte ratio (NLR) (P < 0.0001), albumin-to- lymphocyte ratio (ALR) (P < 0.0001), platelet-to-lymphocyte ratio (PLR) (P = 0.013), and carcinoembryonic antigen (CEA) (P = 0.031). Conditional logistic regression found that CA125 (OR: 1.046; P < 0.0001), CA19-9 (OR: 1.002; P < 0.0001), and FLR (OR: 1.266; P = 0.024) were independent risk factors for GC with PD. The accuracy, sensitivity, specificity, positive predictive value and negative predictive value of the decision rules for detecting PD of GC were 89.5, 77.4, 94.0, 82.8, and 91.8%, respectively. According to the important variables identified by the classification tree and random forest algorithm, the risk assessment model of PD in GC was established. The accuracy, sensitivity, and specificity of the model were 91, 89.5, and 79.5%, respectively.Conclusion: CA125 > 17.3 U/ml, CA19-9 > 27.315 U/ml, and FLR > 2.555 were the risk factors for GC with PD. The decision rules and nomogram model constructed by CA125, CA19-9, CA72-4, and FLR can correctly predict the risk of PD in GC.https://www.frontiersin.org/article/10.3389/fonc.2019.01159/fullgastric cancerperitoneal disseminationrisk factorsdecision rulesrisk assessment model
spellingShingle Chao Huang
Zitao Liu
Li Xiao
Yongqiang Xia
Jun Huang
Hongliang Luo
Zhen Zong
Zhengming Zhu
Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
Frontiers in Oncology
gastric cancer
peritoneal dissemination
risk factors
decision rules
risk assessment model
title Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
title_full Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
title_fullStr Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
title_full_unstemmed Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
title_short Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
title_sort clinical significance of serum ca125 ca19 9 ca72 4 and fibrinogen to lymphocyte ratio in gastric cancer with peritoneal dissemination
topic gastric cancer
peritoneal dissemination
risk factors
decision rules
risk assessment model
url https://www.frontiersin.org/article/10.3389/fonc.2019.01159/full
work_keys_str_mv AT chaohuang clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT zitaoliu clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT lixiao clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT yongqiangxia clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT junhuang clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT hongliangluo clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT zhenzong clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination
AT zhengmingzhu clinicalsignificanceofserumca125ca199ca724andfibrinogentolymphocyteratioingastriccancerwithperitonealdissemination